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The Histone Methyltransferase KMT2B Is Required for RNA
Polymerase II Association and Protection from DNA Methylation at
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Vasileios Ladopoulos,a Helmut Hofemeister,b Maarten Hoogenkamp,a Arthur D. Riggs,c A. Francis Stewart,b Constanze Bonifera
School of Cancer Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdoma; Genomics,
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KMT2B (MLL2/WBP7) is a member of the MLL subfamily of H3K4-specific histone lysine methyltransferases (KMT2) and is
vital for normal embryonic development in the mouse. To gain insight into the molecular mechanism underlying KMT2B func-
tion, we focused onMagohB, which is controlled by a CpG island promoter. We show that in cells lackingMll2—the gene encod-
ing KMT2B—theMagohB promoter resides in inaccessible chromatin and is methylated. To dissect the molecular events leading
to the establishment of silencing, we performed kinetic studies inMll2-conditional-knockout embryonic stem cells. KMT2B de-
pletion was followed by the loss of the active chromatin marks and progressive loss of RNA polymerase II binding with a con-
comitant downregulation ofMagohB expression. Once the active chromatin marks were lost, theMagohB promoter was rapidly
methylated. We demonstrate that in the presence of KMT2B, neither transcription elongation nor RNA polymerase II binding is
required to maintain H3K4 trimethylation at theMagohB promoter and protect it fromDNAmethylation. Reexpression of
KMT2B was sufficient to reinstate an activeMagohB promoter. Our study provides a paradigm for the idea that KMT2 proteins
are crucial components for establishing andmaintaining the transcriptionally active and unmethylated state of CpG island
promoters.
Histone H3 lysine 4 trimethylation (H3K4me3) has been asso-ciated with transcriptionally active promoters (1, 2). Mam-
mals have at least 6 different H3K4-specific methyltransferases; in
mice these are KMT2A (ALL1/CXXC7/MLL1), KMT2B (MLL2/
WBP7), KMT2C (MLL3), KMT2D (MLL4), KMT2E (SET1A),
and KMT2F (SET1B). Murine Mll2 is a paralogue of Mll1 and is
the orthologue of humanMLL4.Mll2 resides on mouse chromo-
some 7 (mm9 chr7: 31353874 to 31369215) and codes for the
KMT2B methlytransferase. These enzymes have at least some
nonredundant functions, as depletion of either KMT2A or
KMT2B is embryonically lethal (3–5). KMT2A is themost studied
of the H3K4 methyltransferases, as it is involved in various leuke-
mogenic translocations (6, 7). These aberrant fusion proteins
function by recruiting a constitutively active, transcriptional elon-
gation-promoting complex to promoters (8–10).
In Saccharomyces cerevisiae, Set1 is the only enzyme responsible
for H3K4me3 deposition and is recruited to the initiating form of
RNA polymerase II (Pol II) (11), suggesting that the H3K4me3
mark is deposited after transcription has initiated. In mice, deple-
tion of KMT2A results in transcriptional silencing, abnormal
RNA polymerase II distribution, loss of histone acetylation, and
CpG island promoter methylation on a subset of the Hox genes
(12–14). These results suggest that KMT2A recruitment is crucial
for the association of the basal transcription machinery and is
involved in setting up a permissive chromatin landscape for tran-
scription as well as preventing DNAmethylation. However, direct
evidence for this idea has so far been lacking.
In contrast to KMT2A, the KMT2B function is less character-
ized. In embryonic stem (ES) cells, only a small number of genes
are significantly downregulated in response to KMT2B depletion,
themost prominent ofwhich isMagohB (15).MagohB is regulated
by a CpG island promoter, and it is expressed in all tissues exam-
ined so far, including ES cells (15). MagohB expression is abso-
lutely dependent on KMT2B in ES cells, with no apparent func-
tional redundancy from other H3K4 methyltransferases.MagohB
transcriptional silencing in the absence of KMT2B is characterized
by loss of H3K4me3 and increased DNA methylation over the
MagohB CpG island promoter (15). This phenomenon is similar
to what has been observed on the Hox genes in cells lacking
KMT2A (12–14). However, the order of events leading to the es-
tablishment of the silenced state is unknown in either case. In
addition, the interdependency between RNA polymerase II bind-
ing and MLL2 association is unclear. We used ES cells carrying a
conditional allele of Mll2 to address these questions and per-
formed kinetic experiments aimed at dissecting the molecular
events leading to MagohB silencing and DNA methylation. Here
we present direct evidence that the presence of KMT2B is required
for the stable maintenance of the basal transcription machinery
and for maintaining low levels of DNA methylation. Our experi-
ments demonstrate that DNA methylation is a rapid process that
is secondary to gene silencing. Moreover, we demonstrate that
reexpression of MLL2 is sufficient to reactivate the methylated
MagohB promoter.
MATERIALS AND METHODS
Cell lines and cell culture.Wild-typemouse ES cells (129P2 background;
here termed E14) and Mll2/, Mll2F/F, and Mll2F/ ES cells (5, 15, 16)
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were provided by A. F. Stewart and were grown in high-glucose Dulbecco
modified Eagle medium supplemented with 15% serum (PAA Gold fetal
bovine serum), 1,000 U/ml leukemia inhibitory factor (ESGRO; Milli-
pore), 25 mM HEPES, 1 mM sodium pyruvate, 2 mM L-glutamine, 100
U/ml penicillin, 100 g/ml streptomycin, 1 nonessential amino acids
(Sigma), and 0.15 mM monothioglycerol at 37°C in 5% CO2 on tissue
culture-grade plastics at a density of 104 cells/cm2. Cells were split every 2
to 3 days as necessary by brief trypsinization in an appropriate volume of
1 trypsin-EDTA at room temperature.
Genotyping. TheMll2F/F andMll2F/ ES cells were tested for recom-
bination of the Mll2 alleles twice by Southern blotting and after that by
PCR and agarose gel electrophoresis every time that they were induced
with 4-hydroxytamoxifen (OHT).OHTwas added to the culturemedium
at a final concentration of 107 M. The genotyping PCR was performed
using primers 145se (CGGAGGAAGAGAGCAGTGACG) and 147as (GG
ACAGGAGTCACATCTGCTAGG). The 145se/147as primer pair detects
allMll2 alleles.
Disruption of RNA polymerase II by -amanitin and DRB. Cells
were grown as described above. 5,6-Dichlorobenzimidazole-1--D-ribo-
furanoside (DRB; Sigma) or-amanitin (Sigma) was added to the culture
medium to give a final concentration of 100 Mor 5 g/ml, respectively.
The cells were cultured for up to 24 h inDRB and up to 48 h in-amanitin
and then harvested using a method suited for the downstream analyses.
Transfections. pCAGGS-FlpO-IRES-puro transfections were per-
formed in 6-well plates using Lipofectamine LTX with Plus reagent
(Invitrogen) according to the manufacturer’s instructions. The trans-
fected cells were grown in puromycin-containing medium for 24 h,
harvested as a bulk population, and expanded for the time periods
indicated in the relevant figures. Cells were cotransfected with 100-
fold less of a green fluorescent protein (GFP)-expressing plasmid. Flu-
orescence-activated cell sorter analysis revealed that at least 95% of
cells expressed GFP.
DNase I-hypersensitive site (DHS)mapping. Themethod employed
for DNase I treatment is an adaptation of the method described by Pfeifer
and Riggs (17). Southern blot transfer and hybridization were performed
as described by Cockerill (18).
In vivo footprinting. Footprinting experiments were performed as
described by Tagoh et al. (19), using Phusion polymerase (New England
Biolabs) and the GC-specific buffer instead of the suggested Pfu polymer-
ase. Micrococcal nuclease (MNase) digestions were performed using the
FIG 1 KMT2B is required forMagohB expression and maintenance of an open chromatin structure on theMagohB promoter. (A) Schematic depiction of the
Mll2 alleles in wild-type (WTMll2) andMll2/ cells. TheMll2 allele contains a STOP cassette composed of a splice acceptor (SA), an internal ribosome entry
sequence (IRES), the-galactosidase gene (lacZ), a neomycin resistance gene (neo), two polyadenylation signals (pA), and a transcriptional terminator sequence
(not shown). Black boxes, Mll2 exons; E14, wild-type (WT) ES cell line; FRT, FLP recombination target. (B) MagohB mRNA expression in wild-type and
knockout cells.MagohB expression is normalized againstGapdhmRNA expression. Bars represent themeans plus SDs of at least 3measurements. (C) Schematic
of the structure of the MagohB locus. CS1, CS2, and CS3, conserved intronic regions. Arrows indicate the positions of the two DNase I-hypersensitive sites
detected within an extended genomic region. (D) Southern blot visualizing the DHSs located within the BamHI fragment using the probe abutting the
downstreamBamHI site, as indicated in panel C. Arrows, the twoDNase I-hypersensitive sites detected. The last two lanes serve as aDNase I-nondigested control
(BamHI) and as size markers (BamHI plus EcoRI/BglII [BamHI EcoRI]).
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same method used for DNase I. Primer sequences used in footprinting
assays are available upon request.
Measurement of DNA methylation. (i) Pyrosequencing. Genomic
DNAwas treated with sodium bisulfite using an EZ-DNAmethylation kit
fromZymoResearch according to themanufacturer’s instructions. Bisul-
fite-converted DNA was used as a PCR template to amplify the MagohB
promoter using biotinylated primers specific for the converted DNA se-
quence (forward sequence, AGTAGAGAAGGTAGAAATTATTATTTA
TAG; reverse sequence, [biotin]-CTCTTAAAAATCTCTTACTTCCTCT
TC). PCR products were purified using streptavidin-coated magnetic
beads and prepared for sequencing using a third sequencing primer (SEQ
[GGTAGAAATTATTATTTATAGATAT]).
(ii) HpaII digestion. Five hundred micrograms of genomic DNA was
digested to completion with HpaII. The digests were used as the template
for quantitative PCRs (QPCRs) with primers flanking a single HpaII site
on the MagohB promoter (MagohB HpaII forward primer, TTCTCTTG
GGGGTCTCTTGCTTCC; MagohB HpaII reverse primer, CGCGTCAC
CAAGGGCGCGTT). Data were subsequently normalized against a PCR
amplicon on the Oct4 promoter that does not contain an HpaII site.
(iii) Methylated DNA immunoprecipitation (MeDIP) and hy-
droxymethylated DNA immunoprecipitation (HmeDIP). Five micro-
grams per immunoprecipitation (IP) of anti-methylated C (ab10805; Ab-
cam) and anti-hydroxymethylated C (ab106918; Abcam) antibody each
was incubated with 10 l protein G Dynabeads (10004D; Life Technolo-
gies) for 2 h at 4°C with rotation. One hundred microliters purified
genomic DNA (2 g/IP) was added to the bead-antibody complexes, and
themixture was incubated overnight at 4°Cwith rotation. The beads were
separated using a magnetic separator and washed once with each of the
following: wash buffer 1 (20 mM Tris, pH 8.0, 2 mM EDTA, 1% Triton
X-100, 0.1% SDS, 150 mM NaCl), wash buffer 2 (20 mM Tris, pH 8.0, 2
mM EDTA, 1% Triton X-100, 0.1% SDS, 500 mM NaCl), and TE-NaCl
buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 50 mM NaCl). Finally, the
immunoprecipitated DNA was eluted in 0.1 M NaHCO3, 1% SDS, 200
mMNaCl containing 200g/ml proteinase K by a 4-h incubation at 65°C.
The eluted DNA was purified using an Agencourt Ampure XP PCR
cleanup kit and used as the template for a QPCR with primers specific for
the MagohB promoter (forward primer, TACTCCGGTAGGAACGAAA;
reverse primer, CTCCAATGCGAACCTTCAGT).
RNA and protein purification. Total RNA and protein were purified
using an RNeasy kit (Qiagen) according to the manufacturer’s instruc-
tions.
cDNA synthesis and QPCR.Moloney murine leukemia virus reverse
transcriptase (Invitrogen) was used to reverse transcribe 1 g total RNA
according to themanufacturer’s instructions.QPCRwas performed on an
ABI 7900HT or ABI 7500 real-time PCR instrument using ABI SYBR
green master mix. Initial data analysis (threshold/baseline) was per-
formed by ABI SDS software, and further analyses were performed in the
Microsoft Excel program. Standard curve quantitation was performed for
all QPCR experiments. The primer sequences used in mRNA expression
measurements were as follows: for Gapdh (glyceraldehyde-3-phosphate
dehydrogenase gene), forward primer ACCTGCCAAGTATGATGAC
ATCA and reverse primer GGTCCTCAGTGTAGCCCAAGAT; for Oct4,
forward primer AGGTGGAACCAACTCCCGAG and reverse primer GC
TTCAGCAGCTTGGCAAC; and forMagohB, forward primer CGGGCA
TAAGGGCAAGTTT, primary RNA forward primer TGGGACTATGAA
ATTGTCTTTACC, and reverse primer AATTACTGTTGTTGGCATAT
GTAAGCTT.
ChIP. Chromatin immunoprecipitation (ChIP) assays were per-
formed as described previously (20) with modifications. ES cells were
fixed in situ by addition of formaldehyde (final concentration, 1%) in the
culture medium and incubation for 12 min. Nuclei were prepared from
the fixed cells, and the contained chromatin was sheared by sonication in
a Diagenode Bioruptor (high setting, 8 cycles of 30 min of pulse and 30
min of pause at 4°C). Immunoprecipitation was performed using anti-
bodies against the RNA Pol II carboxy-terminal domain (CTD) (ab5408;
Abcam), H3K4me3 (07-473; Millipore), and acetylated H3K9 (H3K9ac;
ab4441; Abcam). The immunoprecipitated DNAwas amplified by QPCR
as described above. Primer sequences used in ChIP-QPCR were as fol-
lows: for the MagohB promoter, forward primer TACTCCGGTAGGAA
CGAAA and reverse primer CTCCAATGCGAACCTTCAGT; for the
Oct4 promoter, forward primer TGGGCTGAAATACTGGGTTC and re-
verse primer TTGAATGTTCGTGTGCCAAT.
SDS-PAGE and Western blotting. Whole-cell extracts from equal
amounts of cells were separated on a Bio-Rad 4 to 20% gradient mini-
Protean TGX precast gel. Proteins were transferred onto a nitrocellulose
membrane by wet transfer. Membranes were blocked with 5% (wt/vol)
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FIG 2 Cre-mediated deletion ofMll2 results inMagohB silencing 4 days after OHT treatment. (A) Cre-mediated deletion ofMll2 exon 2 results in a frameshift
and generation of a STOP codon in exon 3. F, conditional allele; FC, null allele. (B) (Top)Mll2 Southern blot distinguishing the differentMll2 alleles before and
after OHT treatment. The image shown is a representative of 2 experiments. WT, wild-type allele; d, days. (Bottom) Quantitation of the Southern blot. The
intensity quantification was performed using the Quantity One software suite (Bio-Rad). (C)MagohBmRNA expression afterMll2 deletion.MagohB expression
is normalized against GapdhmRNA expression. Bars represent the means plus SDs of 4 measurements.
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bovine serum albumin in Tris-buffered saline–Tween. West-pico chemi-
luminescence (Thermo Fisher) was used to visualize the results according
to the manufacturer’s instructions. The primary antibodies used were
ab5408 (Pol II CTD), ab5095 (serine-2-phosphorylated [phospho-S2]
elongating form of Pol II), and ab86601 (Nup188) and are available from
Abcam. The appropriate horseradish peroxidase-conjugated secondary
antibodies were sourced from Jackson ImmunoResearch.
RESULTS
MagohB expression requires KMT2B.Mll2/ ES cells were em-
ployed to investigate the mechanism of MagohB transcriptional
regulation. These cells harbor a gene-trapping cassette in intron 1
of both alleles of Mll2 (Fig. 1A). The nascent Mll2 transcript is
spliced to the cassette, thus preventing expression of wild-type
Mll2.We measuredMagohB steady-state mRNA levels by reverse
transcription-QPCR in the wild-type ES cell line E14 andMll2/
ES cells. As reported previously (15), MagohB expression was
abolished inMll2/ ES cells (Fig. 1B), suggesting that KMT2B is
absolutely required forMagohB expression.
In order to dissect themolecularmechanism bywhich KMT2B
activates or maintains transcription from the MagohB promoter,
we first had to identify potential cis regulatory elements on the
Magoh2B locus. Three conserved intronic regions which could be
regulatingMagohB expressionwere identified (through theUCSC
genome browser’s mammalian conservation plots) and were
termed conserved sequence 1 (CS1), CS2, and CS3 (Fig. 1C). We
then employed DNase I-hypersensitive site (DHS) mapping to
examine the entire MagohB gene and the immediate 5= flanking
region. Hybridization with probes on either side of the restriction
fragment revealed the presence of two DHSs, termed HSp and
HS1 (Fig. 1D; results from hybridization with only one probe are
shown). HSp forms over theMagohBCpG island promoter and is
present only in E14 wild-type cells. Loss of HSp in the Mll2/
cells suggests that KMT2B is involved in maintenance of the open
chromatin conformation of the MagohB promoter. HS1 forms
over a simple repeat element (Fig. 1D and data not shown), pos-
sibly because the DNA sequence of the repeat element is unfavor-
able for nucleosome assembly. In summary, from our data, it is
highly likely that the main element driving expression ofMagohB
is its CpG island promoter.
MagohB is transcriptionally silenced 4 days after de novo
Mll2deletion.To establish the order of events that lead toMagohB
silencing after KMT2B depletion, we employed ligand-dependent
conditional mutagenesis (21). The Mll2F/ and Mll2F/F ES cells
ubiquitously express Cre-ERT2 from the Rosa26 locus and have
one or two conditional Mll2 alleles, respectively (described in
more detail in references 5 and 15). Cre-ERT2 activation by 4-hy-
FIG 3 KMT2B is required to maintain activating histone marks and a stable RNA polymerase II complex on the MagohB promoter. (A) DNase I in vivo
footprinting of theMagohB promoter inOHT-treatedMll2F/F andMll2F/ cells.White bar, region protected fromDNase I; black bars, hypersensitive regions; G,
naked genomicDNA subjected to aMaxam-Gilbert G reaction prior to ligation-mediated PCR; ctrl, in vitroDNase I-digestedDNA; arrow, TSS. Time after OHT
treatment is indicated above the relevant lanes.Mll2/ ES cells were included to demonstrate the DNase I digestion pattern in the inactive state. Annotation on
the left (in base pairs) is relative to the TSS. Primers on the Oct4 promoter were used to verify equal DNase I digestion of all samples. The image shows a
representative of 2 experiments. (B to D) ChIP-QPCR assays using antibodies against H3K4me3 (B), H3K9ac (C), and the RNA polymerase II CTD (D). Data for
histonemodifications were corrected for nucleosome density, as determined by a histoneH3 ChIP assay. Data for RNA polymerase II are corrected for the signal
obtained with input material. Data shown are internally normalized against the signal obtained with primers for theOct4 promoter and presented in relation to
the occupancy measured in E14 wild-type ES cells. Bars represent the means plus SDs of at least 4 measurements.
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droxytamoxifen (OHT) results in deletion ofMll2 exon 2, causing
a frameshift and introducing a stop codonwithin exon 3 (Fig. 2A).
We measured the efficiency and kinetics of Cre-mediated recom-
bination by Southern blotting (Fig. 2B) and found that recombi-
nationwas complete 24 h after OHT induction. These results con-
firm previous studies using the same ES cell system (15), showing
similar recombination kinetics. The study described above had
also demonstrated an approximately 50% reduction of KMT2B
protein 12 h after Cre activation. Importantly, no outgrowth of
nonrecombined cells was observed at up to 8 days postinduction,
as detected by the absence of theMll2F allele in either cell line.
We measured MagohB steady-state mRNA levels over a 4-day
period afterOHT induction (Fig. 2C). AlthoughMll2 deletionwas
complete within 1 day after addition of OHT, the first transcrip-
tional effects on MagohB were observed at 2 days postinduction.
This discrepancy can be attributed to both the stability of the
MagohB mRNA and the half-life of KMT2B. Subsequently, a
nearly complete depletion ofMagohBmRNAwas observed 4 days
after OHT induction. No significant downregulation of MagohB
was observed inMll2F/ cells, indicating that one allele ofMll2 is
sufficient to maintainMagohB expression.
Chromatin structure of theMagohB promoter is perturbed
after KMT2B depletion. To gain insight into the mechanistic de-
tails of the different steps of MagohB silencing, we performed
DNase I footprinting experiments over a time course of 8 days
(Fig. 3A). We observed a characteristic protection from DNase I
digestion around the transcription start site (TSS) flanked by hy-
persensitive regions, suggesting the presence of a protein assem-
bly, most likely the RNA polymerase II preinitiation complex.
This pattern was maintained in the Mll2F/ cells throughout this
time course, consistent with the aforementioned maintenance of
MagohB mRNA levels in those cells. In contrast, the DNase I di-
gestion pattern observed inMll2F/F cells over theMagohB TSS was
altered 4 days after OHT induction, coinciding with the observed
MagohBmRNA depletion. The digestion pattern observed 8 days
after OHT induction very closely resembles the pattern observed
in Mll2/ cells. This experiment demonstrates that the mainte-
nance of DNase I-hypersensitive chromatin over the TSS requires
the presence of KMT2B.
To correlate the reduction in nuclease accessibility with
changes in histone modification patterns, we employed ChIP-
QPCR studies. These assays revealed that loss of KMT2B and
downregulation of gene expression are associated with loss of the
active H3K4me3 and H3K9ac marks (Fig. 3B and C), which was
first observed 2 days after OHT induction in Mll2F/F cells. The
levels of both histone marks decreased to near background levels
at 4 days postinduction, concomitantly with MagohB mRNA de-
pletion. RNApolymerase II levels closely correlatedwith the levels
of these two histone marks (Fig. 3D). Loss of only oneMll2 allele
(Mll2F/ cells) had no effect on the chromatin environment of the
MagohB promoter. These results support the view that KMT2B
and/or the H3K4me3 mark is required for RNA polymerase II
association with theMagohB promoter.
Chromatin architecture atMagohB promoter.DHSs and ac-
tive promoters have previously been reported to be devoid of
nucleosomes (22–26). MNase preferentially cuts in nucleosomal
FIG 4 Nucleosome remodelling over the MagohB promoter 2 days after Mll2 deletion. (A) MNase in vivo footprinting visualizing the vicinity of the
MagohB transcription start site in OHT-treated Mll2F/F cells. Gray bar covering the TSS, moderately increased MNase sensitivity; white bars, protected
regions when comparing digestion patterns observed at the 8-day time point to those at the 0-h time point; G, G reaction; arrow, TSS. The time after OHT
induction is indicated at the top of each lane. Annotation on the left (in base pairs) is relative to the TSS. Primers on theOct4 promoter were used to verify
equal MNase digestion of all samples. The image shows a representative of 2 experiments. (B and C) Nucleosome density over the MagohB promoter 0,
2, and 4 days after OHT treatment of Mll2F/ (B) and Mll2F/F (C) cells. Nucleosome density was measured by histone H3 ChIP followed by QPCR with
primers centered on the positions indicated on the x axis. chr2, chromosome 2, which represents a transcriptionally inactive control region. Bars represent
the means plus SDs of at least 4 measurements.
KMT2B and CpG Island Promoter Regulation
April 2013 Volume 33 Number 7 mcb.asm.org 1387
 o
n
 January 14, 2016 by University of Birm
ingham
http://m
cb.asm
.org/
D
ow
nloaded from
 
linker regions in chromatin (27, 28), which can be visualized as
strong double-strand cuts in high-resolutionmapping assays (19).
In addition, large nonhistoneDNA-protein complexes can also be
indicated by flanking MNase cuts (29). We therefore employed
MNase footprinting to examine the chromatin architecture of the
MagohB promoter after deletion of Mll2. Identical MNase diges-
tion patterns were observed in untreatedMll2F/F andMll2F/ cells
with strong MNase cuts flanking the TSS and the active RNA
polymerase II complex. This digestion pattern, especially the
strong flanking sites, remained unchanged inMll2F/ cells up to 8
days after OHT induction. InMll2F/F cells, however, it was altered
2 days after OHT induction (Fig. 4A). Changes in MNase accessi-
bility were also observed further downstream (data not shown).
These findings confirmed the DNase I data demonstrating that
upon loss of KMT2B, nuclease accessibility on the MagohB pro-
moter and surrounding region was altered. To clarify whether
these changeswere due to nucleosome repositioning or eviction of
the basal transcriptionmachinery and/or other protein factors, we
performedChIP experiments using an antibody raised against his-
tone H3 (Fig. 4B and C). These experiments demonstrated that
nucleosomes on the MagohB CpG island promoter were only
loosely positioned, if at all, consistent with previously reported
findings with CpG island promoters (30). Most importantly, we
did not detect major alterations in the nucleosome occupancy
pattern at theMagohB promoter up to 8 days afterOHT treatment
inMll2F/ (Fig. 4B) orMll2F/F (Fig. 4C) ES cells.
DNA methylation occurs soon after transcriptional silenc-
ing. To directly investigate whether DNA methylation is a silenc-
ing initiating or maintaining event, we measured DNA methyl-
ation levels on the MagohB CpG island promoter region by
bisulfite conversion and pyrosequencing over an 8-day time
course. A total of 19 CpG sites distributed between bp 48 and
69 from the transcription start site were examined in this assay.
The results showed no significant difference in DNAmethylation
inMll2F/ cells over the duration of this time course (Fig. 5A). In
contrast, increased DNA methylation at the MagohB promoter
FIG 5 Rapid DNAmethylation of theMagohB CpG island after KMT2B depletion. Cytosine modification levels on a part of theMagohB CpG island promoter
in Mll2F/ (A) and Mll2F/F (B) cells were measured by bisulfite conversion and subsequent pyrosequencing. The cells were induced with OHT at 0 days and
harvested at the timepoints indicated on the z axis.DNAmethylation levelsmeasured inMll2/ cells are inserted as a separate point on the z axis for comparison.
Each point on the x axis represents an individual CpG dinucleotide. (C) Data presented in panels A and B summarized in a box plot format. Analysis was
performed using SPSS. Hatched line, median DNAmethylation level inMll2/ cells; black bars, median CpG methylation over the region examined (bp48
to 69); boxes, 95% confidence interval; whiskers, 99% confidence interval; open circle, outlier. (D) MeDIP-QPCR with primers specific for the MagohB
promoter inMll2F/ andMll2F/F ES cells 0, 4, and 8 days after OHT treatment. 5=-meC, 5=methylated C. Bars represent themeans plus SDs of 3 experiments. (E)
HmeDIP-QPCR with primers specific for the MagohB promoter in Mll2F/ and Mll2F/F ES cells 0, 4, and 8 days after OHT treatment. 5=-hmeC, 5= hydroxy-
methylated C. Bars represent means SDs of 3 experiments.
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was evident inMll2F/F cells 4 days after OHT induction (Fig. 5B).
At this time point, theH3K4me3 andH3K9ac histonemarks along
with RNA polymerase II had already been removed and transcrip-
tion had ceased. We therefore conclude that DNA methylation
cannot be responsible for initiating MagohB silencing in those
cells. As no clear bias toward methylation (or protection from
methylation) of specific CpG dinucleotides was observed, the
three-dimensional graphs presented in Fig. 4A and B were sum-
marized in a simpler box plot format (Fig. 5C). This representa-
tion revealed a significant (at 95% confidence) overall increase in
CpGmethylation on theMagohB promoter inMll2F/F cells 4 days
after OHT treatment. At the 8-day time point, CpG methylation
on theMagohB promoter inMll2F/F cells equalled the levels mea-
sured inMll2/ cells. As thismethod cannot distinguish between
cytosine methylation and hydroxymethylation, we performed
MeDIP andHmeDIP assays coupledwithQPCR.Wemeasured an
increase in methylcytosine levels on theMagohB promoter exclu-
sively in Mll2F/F cells at 4 and 8 days after OHT treatment (Fig.
5D), but hydroxymethylcytosine levels in both Mll2F/ and
Mll2F/F ES cells were low (Fig. 5E). Importantly, the levels of this
modification did not change after KMT2B depletion, verifying
that what we detected by bisulfite conversion and pyrosequencing
is indeed DNA methylation.
Transcription and RNA polymerase II are dispensable for
themaintenance of theH3K4me3mark and for protection from
DNAmethylation. A recent study reports that theDrosophila ho-
mologue of KMT2B—Trx—is found to rapidly reassociate with
nascent DNA after the passage of the replication fork, while
H3K4-methylated histones are detected onlymuch later (31). Ad-
ditionally, a previous report has shown that KMT2A remains
bound on highly condensed mitotic chromosomes and marks
genes that will be rapidly and highly induced upon entry of the cell
into G1 phase (32). During cell division, transcription ceases and
RNApolymerase II is evicted fromDNA.KTM2proteins in higher
eukaryotes therefore appear to be able to bind independently of
RNA polymerase II association. To gain insight into the role of
KMT2B in the absence of transcription and/or RNA polymerase
II,Mll2F/F cells were treated with DRB or -amanitin. DRB blocks
transcriptional elongation by inhibiting p-TEFb enzymatic activ-
ity (33, 34). -Amanitin binds the active site of RNA polymerase
II, and this complex is subsequently targeted for degradation (35).
Western blotting using whole-cell extracts demonstrated that the
serine-2-phosphorylated elongating form of RNA polymerase II
was depleted after 16 h of DRB treatment, while a 24- or 48-h
-amanitin treatment greatly reduced total RNA polymerase II
levels (Fig. 6A). As expected, MagohB primary transcripts (Fig.
6B) and steady-state mRNA (data not shown) were barely detect-
able following treatment with either of the two drugs. Gapdh ex-
pression levels were found to be just above detection limits (data
not shown), demonstrating that this effect was not confined to
MagohB. Importantly, 18S rRNA could be readily detected, as
RNA polymerase I is reported to be unaffected by either of these
drugs (data not shown).
We next examined the chromatin state at the MagohB pro-
FIG 6 The H3K4me3 mark and protection from DNA methylation persist on the MagohB promoter, despite a block in transcription and a decrease in RNA
polymerase II association. (A)Western blot analysis of DRB- and -amanitin-treatedMll2F/F cells, using whole-cell protein extracts. Arrow, band for phospho-
serine 2 RNA polymerase II; asterisk, a nonspecific band. Dimethyl sulfoxide (DMSO)-treated samples were used as a control to exclude drug carrier effects. An
antibody against nucleoporin Nup188 was used to verify equal sample loading. The image shown is a representative of 2 individual experiments. (B) Reverse
transcription-QPCR detecting primaryMagohBRNA inDRB- and-amanitin-treated cells. Data presented here are normalized to the level of 18S rRNA, which
is transcribed by RNA polymerase I. Bars represent the means plus SDs of 4 measurements. (C) ChIP with antibodies against H3K4me3 and RNA polymerase II
CTD. Data for histonemodifications are corrected for nucleosome density, as determined by a histoneH3 IP assay. Data for RNA polymerase II are corrected for
input. The data presented are plotted as the fold change over the results for dimethyl sulfoxide-treated cells. Bars represent themeans plus SDs of 4measurements.
(D) DNA methylation levels were measured by QPCR with primers spanning a single HpaII site after HpaII digestion. Methylation levels of the same CpG
dinucleotide 8 days after OHT treatment ofMll2F/F cells (FC/FC) are shown for comparison. Data presented here were normalized over an amplicon on theOct4
promoter that does not contain anHpaII site. N/A, not assayed. Dimethyl sulfoxide-treated cells were used to exclude any drug carrier effects. Bars represent the
means plus SDs of 4 measurements.
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moter by ChIP-QPCR.We did not observe any difference in RNA
polymerase II occupancy or H3K4me3 levels in DRB-treated cells
(Fig. 6C).Wemeasured an approximately 50% reduction in RNA
polymerase II occupancy over the MagohB promoter in cells
treated with -amanitin, accompanied by an approximately
2-fold increase in H3K4me3 levels. The increase in H3K4me3
could be explained by the loss of H3K4-specific demethylases as a
result of RNA polymerase II inhibition. These findings support
the notion that H3K4me3 deposition and maintenance on the
MagohB promoter do not require RNA polymerase II recruitment
and transcription.
To testwhether the reduction in elongationorRNApolymerase II
occupancy increased DNA methylation at the MagohB CpG island
promoter, we examined DNA methylation levels after DRB or
-amanitin treatment by HpaII digestion and QPCR. We did not
observe any increase in methylation of this particular CpG dinucle-
otide following either treatment. This result suggests that in the pres-
ence ofKMT2B, protection fromDNAmethylationdoes not depend
on productive transcriptional elongation and is not affected by a se-
vere depletion of RNA polymerase II binding. The presence of
KMT2B and/or the H3K4me3 mark is sufficient to protect the
MagohB promoter from the action of DNAmethyltransferases.
Reactivation of endogenousMll2 alleles is sufficient to revert
MagohB to the active state. In order to examine whether DNA
methylation permanently locks the MagohB promoter in the in-
active state, we reactivated the endogenousMll2 alleles inMll2/
cells by transient expression of the FlpO recombinase. Expression
of FlpO results in removal of the stop cassette and expression of
wild-type KMT2B from the endogenous locus (Fig. 7A).Mll2/
cells were transfected with a pCAGGS-FlpO-puro plasmid and
enriched by culturing in 1 g/ml puromycin-containing medium
for 24 h. Successful deletion of the stop cassette and reactivation of
Mll2 were verified by genotyping PCR (data not shown) andMll2
steady-state mRNA expression measurement (Fig. 7B). Upon re-
introduction of KMT2B (14 days posttransfection), MagohB
mRNA could be readily detected (Fig. 7B), suggesting that
KMT2B action can overcome the repressive barrier posed byDNA
methylation. MagohB reactivation was accompanied by the rees-
tablishment of the H3K4me3mark on theMagohB promoter (Fig.
7C), as shown by ChIP-QPCR assays performed at the same time
point. Both cytosine methylation (Fig. 7D) and 5= hydroxymethyl-
ation (Fig. 7E) were detected and progressively decreased on the
MagohB promoter. Our results suggest that reactivation of the
endogenous Mll2 alleles and physiological levels of KMT2B ex-
pression are sufficient to reestablish the normal H3K4me3 pattern
and to induceDNAdemethylation,most likely via a 5= hydroxym-
ethylcytosine intermediate.
FIG 7 Reactivation of the endogenous Mll2 alleles in Mll2/ ES cells is sufficient to reactivate MagohB. (A) The stop cassette was excised by FlpO-mediated
recombination, allowing transcription of full-lengthMll2. Black boxes,Mll2 exons. (B)MagohB andMll2 expression relative to expression levels in E14wild-type
ES cells. pCAGGS-FlpO-puro-transfected Mll2/ cells were harvested at 14 days posttransfection. Mock, pMAX-GFP-transfected Mll2/ ES cells. Bars
represent the means plus SDs of at least 4 measurements. (C) H3K4me3 ChIP followed by QPCR with primers specific for the loci indicated on the x axis.
FlpO-transfected cells were cultured for 14 days posttransfection. Bars represent themeans plus SDs of at least 4measurements. (D)MeDIP-QPCRwith primers
specific for the MagohB promoter in Mll2F/F and mock- and FlpO-transfected Mll2/ ES cells, as indicated. Data are presented in relation to the enrichment
measured in mock-transfectedMll2/ cells. FlpO-transfected cells were harvested at the time points indicated on the x axis. Bars represent the means plus SDs
of 3 experiments. (E) HmeDIP-QPCRwith primers specific for theMagohB promoter inMll2F/F andmock- and FlpO-transfectedMll2/ ES cells, as indicated.
Data are presented in relation to the enrichment measured in mock-transfectedMll2/ cells. FlpO-transfected cells were harvested at the time points indicated
on the x axis. Bars represent the means plus SDs of 3 experiments.
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DISCUSSION
KMT2B is required to establish andmaintain an active chroma-
tin environment and recruit RNA polymerase II to theMagohB
promoter.The inducibleMll2-knockout system allowed us to dis-
sect the order of events leading toMagohB silencing and demon-
strate that it occurs in a sequential fashion. After KMT2B deple-
tion, the levels of the H3K4me3 mark decrease (herein and
reference 15) with a concomitant decrease in both H3K9 acetyla-
tion and RNA polymerase II association with the MagohB pro-
moter, resulting in transcriptional silencing. Additionally, the
MagohB promoter lacksDNase I hypersensitivity in the absence of
KMT2B, as shown by our DHS mapping experiments inMll2/
cells.
In summary, from our data it is likely that KMT2B forms a
platform that coordinates the assembly of the basal transcription
machinery via multiple interactions. The transactivation domain
of KMT2A has been shown to interact directly with CBP/p300-
containing histone acetyltransferase (HAT) complexes (36). HAT
complexes are known to act as large multiprotein scaffolds that
can mediate interactions between transcription factors and the
basal transcription machinery (37). KMT2B may be involved in
stabilizing the recruitment of CBP/p300-containing complexes,
which can in turn recruit the transcriptional apparatus. The pre-
initiation complex may be further stabilized by TFIID binding to
H3K4-trimethylated nucleosomes (38, 39) flanking the MagohB
promoter. Thismodel predicts that loss of KMT2Bwould result in
loss of histone acetylation and RNA polymerase II, which is pre-
cisely what we observed.
KMT2Baction is not dependent on transcriptionor thepres-
ence of RNA polymerase II. Our experiments using DRB and
-amanitin demonstrate that in the presence of KMT2B, RNA
polymerase II recruitment and transcriptional elongation are
largely dispensable for the maintenance of H3K4 trimethylation.
This result is consistent with the hypothesis that MLL proteins
(KMT2A toKMT2D) operate differently from yeast Set1 and have
a causal role in transcriptional activation. Previous studies have
hinted to such a mechanism, as depletion of KMT2A resulted in
changes in RNA polymerase II distribution on KMT2A target
genes (12, 13). Moreover, it has been demonstrated that CpG is-
lands recruit H3K4 methyltransferases regardless of their tran-
scriptional activity (40). Our experiments provide direct evidence
that neither active transcription nor the presence of theRNApoly-
merase II preinitiation complex is required to maintain the
H3K4me3 mark over a CpG island promoter, further suggesting
that MLL (KMT2A to KMT2D) proteins act upstream of RNA
polymerase II recruitment.
KMT2B confers protection from DNA methylation. How
CpG islands are protected from DNA methylation has been a
long-standing subject of research. Our data clearly demonstrate
that loss of the H3K4me3 mark results in the rapid onset of DNA
methylation atmultiple CpG dinucleotides over theMagohBCpG
island promoter. Moreover, transcriptional elongation and RNA
polymerase II did not appear to play a role inMagohBmethylation
protection, as illustrated by our experiments using DRB and
-amanitin. In turn, we show that reexpression of KMT2B is suf-
ficient to induce demethylation of the methylated MagohB pro-
moter, the reestablishment of its normal H3K4me3 pattern, and
the activation of transcription (Fig. 7D and E). This indicates that
once all activators are present, the RNA polymerase II complex
efficiently reassociates and overrides the silent state. It has previ-
ously been demonstrated that H3K4me3 may confer protection
fromDNAmethylation (41), as the DNAmethyltransferase com-
mon subunit—DNMT3L—can interact only with unmethylated
H3K4. As such, KMT2 catalytic activity would preclude DNA
methyltransferase recruitment, thus conferring protection from
DNA methylation to KMT2 target promoters. In addition, phys-
ically retaining KMT2B on chromatin during replicationmay fur-
ther protect fromDNAmethyltransferase action. The detailed dis-
section of these processes is a current subject of further
experimentation outside the scope of this study.
KMT2B in CpG island promoter regulation. Based on our
results, we propose a model for the role of KMT2B in MagohB
transcriptional regulation (Fig. 8). After KMT2B depletion, the
H3K4me3 mark is either actively removed or diluted over consec-
utive cell divisions, resulting in loss of the H3K9ac mark. RNA
polymerase II can no longer associate with theMagohB promoter,
as its recruitment may be facilitated or stabilized by direct inter-
actions of TFIIDwith theH3K4me3mark (38, 39) and interactions
with CBP/p300-containing HAT complexes (36, 37). As the pre-
initiation complex is removed, transcription ceases. After the
H3K4me3 mark and/or KMT2B has been removed from the
MagohB promoter, DNAmethyltransferases are able to target and
de novomethylate theMagohB CpG island.We believe that such a
scenario is avoided at most genes by the high level of redundancy
FIG 8 Model for MagohB silencing following KMT2B depletion. KMT2B is
normally recruited to theMagohB promoter by transcription factors, by inter-
action of the PHD fingers with H3K4me3, or through CXXC domain binding
to nonmethylated CpG dinucleotides. After Mll2 deletion, H3K4me3 and
H3K9ac are gradually depleted from theMagohBpromoter andRNApolymer-
ase II is lost, leading to transcriptional silencing. This is finally followed by
DNA methylation and loss of the DNase I-hypersensitive site.
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within the KMT2 family of histone methyltransferases. However,
the specific developmental defects of individual KMT2 family
member knockouts indicate that windows in development exist
where the dynamic activation of genes becomes dependent on a
specific family member. Currently, the transcription factors re-
cruiting KMT2A/B-containing complexes are not known. The
MagohB promoter binds Sp1 and Sp3 in vitro, but no binding
could be detected in ChIP experiments, and deletion of either
factor individually did not influence MagohB mRNA levels (data
not shown). Whatever recruits KMT2A/B complexes, our model
helps to explain why once a transcriptional network has been de-
stabilized in the context of tumorigenesis, CpG island promoters
become vulnerable to gene silencing.
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